Two former drug salesmen for Johnson & Johnson could make hundreds of millions of dollars if they are successful in winning their case against their former employer, saving American's nearly $3 billion dollars. Mark Duxbury and Dean McClellan claim that Ortho BioTech, a subsidiary of Johnson & Johnson, has been making false claims within the Medicare program, and these whistleblowers could make between 15% to 30% of the amount recovered by the US government. The two salesmen claim that the company has been paying doctors what are referred to as "kickbacks" in order to motivate them to prescribe the anti-anemia drug Procrit to their patients. Some of these kickbacks came in the form of rebates, discounts and other benefits, yet Medicare was paying full price when it reimbursed patients for their prescriptions. Both men and their families have received significant pressure from their former employees, friends and relationships throughout this process. This program falls under the False Claims Act which was passed under the administration of President Lincoln during the American Civil War. This war was marked by tremendous fraud on all sides within the government, as unscrupulous contractors were able to sell the Union Army a variety of faulty weaponry, mules, and ammunition. The provision was created in order to allow citizens to sue on behalf of the government with the benefit of retaining a percentage of the dollars recovered, sometimes referred to as a Qui tam case. These cases have become a valuable tool in assisting government in combating a growing amount of fraud within their systems, recovering about $1.3 billion in 2008 while paying out nearly $200 million to the individuals bringing the crime to light. A federal court reinstated a False Claims Act lawsuit filed by former pharmaceutical salesmen Mark Duxbury and Dean McClellan against Johnson & Johnson subsidiary Ortho Biotech. The men claim that Ortho Biotech cheated Medicare by giving doctors kickbacks to prescribe the anti-anemia drug Procrit. Doctors were allegedly given discounts, rebates and other perks to prescribe and administer the drug while Medicare was charged full price to reimburse prescriptions. More on this topic can be read on CBS News.com: http://www.cbsnews.com/8301-505123_162-42842558/drug-rep-in-3b-procrit-c...